Patents by Inventor Jason M. Guernon

Jason M. Guernon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-aryl thiazole derivatives as KCNQ modulators
    Patent number: 7273866
    Abstract: Novel 2-arylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders that are responsive to the opening of the KCNQ potassium channels, including pain and migraine
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: September 25, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kenneth M. Boy, Yong-Jin Wu, Jason M. Guernon
  • 2-aryl thiazole derivatives as KCNQ modulators
    Publication number: 20040147401
    Abstract: Novel 2-arylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders that are responsive to the opening of the KCNQ potassium channels, including pain and migraine.
    Type: Application
    Filed: December 9, 2003
    Publication date: July 29, 2004
    Inventors: Kenneth M. Boy, Yong-Jin Wu, Jason M. Guernon